« Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study » has been published in The Lancet Neurology. This work was supported in part by JPND through the ALS-CarE project, selected in the 2012 Healthcare Evaluation call.
mars 13, 2018